{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:27:41Z","timestamp":1758378461413,"version":"3.44.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013128","name":"MSA Trust","doi-asserted-by":"crossref","award":["2022\/93022"],"award-info":[{"award-number":["2022\/93022"]}],"id":[{"id":"10.13039\/100013128","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Speech problems are an early feature of Multiple System Atrophy (MSA). They can lead to social withdrawal and have significant impact on people\u2019s quality of life. There is a considerable lack of clinical trials and clinicians lack guidance on how best to support this population. This project aimed to establish the feasibility and acceptability of a novel treatment approach, ClearSpeechTogether, in patients with the cerebellar variant of MSA (MSA-C), and to pilot an RCT comparing this treatment to standard speech and language therapy (SLT) treatment (ST). We recruited 24 patients with clinically probable MSA-C and dysarthria who were randomised to either treatment arm. Full data were available for 9 participants for ST, and 11 for ClearSpeechTogether. Both interventions lasted 6 weeks, ST offered 1\u00a0h of individual therapy a week, ClearSpeechTogether provided four individual therapy sessions over two weeks, followed by four weeks of daily, patient led group practice. Assessment and intervention were provided online via videoconferencing software. Data collection focused on feasibility, acceptability and signal of efficacy. Recruitment, conversion and attrition rates were within or close to target, and neither participants nor clinicians highlighted any acceptability issues. Communication outcomes were mixed, with biggest gains made in communication confidence and participation across both groups. Rapid decline in overall health status appeared to have impacted results. Results were generally positive and support the implementation of larger follow up trials. The study also demonstrated that people with MSA-C can benefit from speech therapy even at more severe stages of their disease progression.<\/jats:p>","DOI":"10.1007\/s12311-025-01895-y","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T09:21:38Z","timestamp":1755163298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Speech Treatment for People with Cerebellar Multiple System Atrophy (MSA-C): A Pilot Randomised Controlled Trial of Two Approaches"],"prefix":"10.1007","volume":"24","author":[{"given":"Anja","family":"Lowit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Priya","family":"Shanmugarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanna","family":"Duty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Stanier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Kobylecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Hadjivassiliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"5","key":"1895_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/mds.23580","volume":"26","author":"H-J Kim","year":"2011","unstructured":"Kim H-J, et al. Survival of Korean patients with multiple system atrophy. Mov Disord. 2011;26(5):909\u201312.","journal-title":"Mov Disord"},{"issue":"2","key":"1895_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/mds.21839","volume":"23","author":"A Schrag","year":"2008","unstructured":"Schrag A, et al. Survival in multiple system atrophy. Mov Disord. 2008;23(2):294\u20136.","journal-title":"Mov Disord"},{"issue":"2","key":"1895_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/archneur.58.2.259","volume":"58","author":"J Muller","year":"2001","unstructured":"Muller J, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001;58(2):259\u201364.","journal-title":"Arch Neurol"},{"issue":"5","key":"1895_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/jnnp-2016-314956","volume":"88","author":"SA Glasmacher","year":"2017","unstructured":"Glasmacher SA, Leigh PN, Saha RA. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88(5):402\u201311.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1895_CR5","first-page":"66","volume":"18","author":"Y Kim","year":"2010","unstructured":"Kim Y, et al. Perceptual and acoustic features of dysarthria in multiple system atrophy. J Med Speech - Lang Pathol. 2010;18:66.","journal-title":"J Med Speech - Lang Pathol"},{"issue":"6","key":"1895_CR6","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s00415-019-09271-7","volume":"266","author":"J Rusz","year":"2019","unstructured":"Rusz J, et al. Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy. J Neurol. 2019;266(6):1394\u2013404.","journal-title":"J Neurol"},{"issue":"3","key":"1895_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2217\/nmt-2017-0005","volume":"7","author":"N Miller","year":"2017","unstructured":"Miller N, et al. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of parkinson\u2019s disease, PSP and MSA-P. Neurodegenerative Disease Manage. 2017;7(3):191\u2013203.","journal-title":"Neurodegenerative Disease Manage"},{"issue":"8","key":"1895_CR8","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/mds.21992","volume":"23","author":"M K\u00f6llensperger","year":"2008","unstructured":"K\u00f6llensperger M, et al. Red flags for multiple system atrophy. Mov Disord. 2008;23(8):1093\u20139.","journal-title":"Mov Disord"},{"issue":"2","key":"1895_CR9","first-page":"185","volume":"1","author":"K Gustaw","year":"2007","unstructured":"Gustaw K, Gonet W. Speech disorders in multiple system atrophy of Parkinson type. J Pre-Clinical Clin Res. 2007;1(2):185\u20138.","journal-title":"J Pre-Clinical Clin Res"},{"issue":"3","key":"1895_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/09638288.2010.511685","volume":"33","author":"M Walshe","year":"2011","unstructured":"Walshe M, Miller N. Living with acquired dysarthria: the speaker\u2019s perspective. Disabil Rehabil. 2011;33(3):195\u2013203.","journal-title":"Disabil Rehabil"},{"key":"1895_CR11","doi-asserted-by":"crossref","unstructured":"Lowit A, et al. Symptom burden of people with progressive ataxia, and its wider impact on their friends and relatives: a cross-sectional study [version 1; peer review: awaiting peer review]. AMRC Open Research. 2021;3(28).","DOI":"10.12688\/amrcopenres.13036.1"},{"key":"1895_CR12","doi-asserted-by":"crossref","unstructured":"Park A et al. Swallowing Outcomes Following Voice Therapy in Multiple System Atrophy with Dysphagia: comparison of Treatment Efficacy with Parkinson\u2019s Disease. Dysphagia. 2021.","DOI":"10.1007\/s00455-021-10265-9"},{"issue":"4","key":"1895_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.13064\/KSSS.2018.10.4.163","volume":"10","author":"Y Park","year":"2018","unstructured":"Park Y. Efficacy of intensive treatment of dysarthria for people with multiple system atrophy. Phonetics Speech Sci. 2018;10(4):163\u201371.","journal-title":"Phonetics Speech Sci"},{"issue":"3","key":"1895_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.12963\/csd.20734","volume":"25","author":"H-R Chae","year":"2020","unstructured":"Chae H-R, Choi SH, Choi C-H. Treatment efficacy of dysarthria in patients with multiple system atrophy using water resistance therapy. Commun Sci Disord. 2020;25(3):750\u201363.","journal-title":"Commun Sci Disord"},{"issue":"3","key":"1895_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1044\/2020_JSLHR-20-00259","volume":"64","author":"Y Sonoda","year":"2021","unstructured":"Sonoda Y, et al. Short-Term effect of intensive speech therapy on dysarthria in patients with sporadic spinocerebellar degeneration. J Speech Lang Hear Res. 2021;64(3):725\u201333.","journal-title":"J Speech Lang Hear Res"},{"issue":"11","key":"1895_CR16","first-page":"e73106","volume":"16","author":"K Hayashi","year":"2024","unstructured":"Hayashi K, et al. Effectiveness of Lee Silverman voice treatment (LSVT-LOUD) in Parkinsonian-Type multiple system atrophy (MSA-P): A case report. Cureus. 2024;16(11):e73106.","journal-title":"Cureus"},{"key":"1895_CR17","doi-asserted-by":"publisher","first-page":"e078341","DOI":"10.1136\/bmj-2023-078341","volume":"386","author":"CM Sackley","year":"2024","unstructured":"Sackley CM, et al. Lee Silverman voice treatment versus NHS speech and Language therapy versus control for dysarthria in people with parkinson\u2019s disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial. BMJ. 2024;386:e078341.","journal-title":"BMJ"},{"key":"1895_CR18","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/mds.27460","volume":"33","author":"LO Ramig","year":"2018","unstructured":"Ramig LO, et al. Speech treatment in parkinson\u2019s disease: randomized controlled trial (RCT). Mov Disord. 2018;33:1777\u201391.","journal-title":"Mov Disord"},{"issue":"5","key":"1895_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12311-022-01462-9","volume":"22","author":"A Lowit","year":"2023","unstructured":"Lowit A, et al. ClearSpeechTogether: a rater blinded, single, controlled feasibility study of speech intervention for people with progressive ataxia. Cerebellum. 2023;22(5):865\u201376.","journal-title":"Cerebellum"},{"key":"1895_CR20","unstructured":"Scotland CMO. Delivering Value Based Health & Care: A Vision For Scotland, C.M.O. Directorate, Editor. 2022."},{"key":"1895_CR21","unstructured":"Scotland CMO. Realistic Medicine - Taking Care. 2024."},{"issue":"2","key":"1895_CR22","first-page":"189","volume":"46","author":"N Miller","year":"2011","unstructured":"Miller N, et al. National survey of speech and Language therapy provision for people with parkinson\u2019s disease in the united kingdom: therapists\u2019 practices. Int J Lang Communication Disorders. 2011;46(2):189\u2013201.","journal-title":"Int J Lang Communication Disorders"},{"key":"1895_CR23","doi-asserted-by":"crossref","unstructured":"Lowit A et al. ClearSpeechTogether versus standard NHS speech intervention: Study protocol for a single, mixed method, rater blinded pilot randomised controlled trial for people living with MSA-C. Research Square. (June. 2023). Preprint(Version 1, 14 2023).","DOI":"10.21203\/rs.3.rs-3064044\/v1"},{"issue":"6","key":"1895_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, et al. The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022;37(6):1131\u201348.","journal-title":"Mov Disord"},{"issue":"11","key":"1895_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717\u201320.","journal-title":"Neurology"},{"issue":"1","key":"1895_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1044\/2015_AJSLP-14-0113","volume":"25","author":"S Park","year":"2016","unstructured":"Park S, et al. Be clear: A new intensive speech treatment for adults with nonprogressive dysarthria. Am J Speech-Language Pathol. 2016;25(1):97\u2013110.","journal-title":"Am J Speech-Language Pathol"},{"issue":"11","key":"1895_CR27","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/mds.27460","volume":"33","author":"L Ramig","year":"2018","unstructured":"Ramig L, et al. Speech treatment in parkinson\u2019s disease: randomized controlled trial (RCT). Mov Disord. 2018;33(11):1777\u201391.","journal-title":"Mov Disord"},{"key":"1895_CR28","volume-title":"Clinician instructions","author":"A Lowit","year":"2024","unstructured":"Lowit A. ClearSpeechTogether: Clinician instructions. Glasgow: University of Strathclyde; 2024."},{"key":"1895_CR29","volume-title":"ClearSpeechTogether: exercise manual for group sessions","author":"A Lowit","year":"2024","unstructured":"Lowit A, Cox J. ClearSpeechTogether: exercise manual for group sessions. 3 ed. Glasgow: University of Strathclyde; 2024.","edition":"3"},{"issue":"4","key":"1895_CR30","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1044\/1092-4388(2012\/12-0140)","volume":"56","author":"C Baylor","year":"2013","unstructured":"Baylor C, et al. The communicative participation item bank (CPIB): item bank calibration and development of a Disorder-Generic short form. J Speech Lang Hear Res. 2013;56(4):1190\u2013208.","journal-title":"J Speech Lang Hear Res"},{"issue":"3","key":"1895_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jvoice.2012.10.012","volume":"27","author":"NP Solomon","year":"2013","unstructured":"Solomon NP, et al. Utility of the voice handicap index as an indicator of postthyroidectomy voice dysfunction. J Voice. 2013;27(3):348\u201354.","journal-title":"J Voice"},{"issue":"3","key":"1895_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1044\/1092-4388(2002\/033)","volume":"45","author":"G Weismer","year":"2002","unstructured":"Weismer G, Laures JS. Direct magnitude estimates of speech intelligibility in dysarthria: effects of a chosen standard. J Speech Lang Hear Res. 2002;45(3):421\u201333.","journal-title":"J Speech Lang Hear Res"},{"issue":"2","key":"1895_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1044\/1058-0360(2008\/08-0017)","volume":"18","author":"GB Kempster","year":"2009","unstructured":"Kempster GB, et al. Consensus auditory-perceptual evaluation of voice: development of a standardized clinical protocol. Am J Speech Lang Pathol. 2009;18(2):124\u201332.","journal-title":"Am J Speech Lang Pathol"},{"issue":"1","key":"1895_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1044\/1058-0360(2010\/09-0105)","volume":"20","author":"RI Zraick","year":"2011","unstructured":"Zraick RI, et al. Establishing validity of the consensus Auditory-Perceptual evaluation of voice (CAPE-V). Am J Speech-Language Pathol. 2011;20(1):14\u201322.","journal-title":"Am J Speech-Language Pathol"},{"issue":"6","key":"1895_CR35","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jvoice.2012.03.005","volume":"26","author":"K Nemr","year":"2012","unstructured":"Nemr K, et al. GRBAS and Cape-V scales: high reliability and consensus when applied at different times. J Voice. 2012;26(6):812. .e17-812.e22.","journal-title":"J Voice"},{"issue":"3","key":"1895_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1044\/1058-0360.0603.66","volume":"6","author":"BH Jacobson","year":"1997","unstructured":"Jacobson BH, et al. The voice handicap index (VHI): development and validation. Am J Speech-Language Pathol. 1997;6(3):66\u201370.","journal-title":"Am J Speech-Language Pathol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-025-01895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-025-01895-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-025-01895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:32:29Z","timestamp":1758357149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-025-01895-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1007\/s12311-025-01895-y","relation":{},"ISSN":["1473-4230"],"issn-type":[{"type":"electronic","value":"1473-4230"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"142"}}